USA Financial Formulas Boosts Stock Position in Exelon Corporation $EXC

USA Financial Formulas lifted its position in Exelon Corporation (NASDAQ:EXC) by 13,092.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 20,184 shares of the company’s stock after purchasing an additional 20,031 shares during the quarter. USA Financial Formulas’ holdings in Exelon were worth $880,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of EXC. Wealthcare Advisory Partners LLC lifted its stake in Exelon by 27.5% during the 4th quarter. Wealthcare Advisory Partners LLC now owns 33,138 shares of the company’s stock valued at $1,444,000 after acquiring an additional 7,140 shares during the period. Romano Brothers AND Company raised its holdings in shares of Exelon by 6.8% during the fourth quarter. Romano Brothers AND Company now owns 8,696 shares of the company’s stock worth $379,000 after purchasing an additional 550 shares during the last quarter. Norden Group LLC lifted its position in Exelon by 13.8% during the fourth quarter. Norden Group LLC now owns 12,675 shares of the company’s stock valued at $553,000 after purchasing an additional 1,541 shares during the period. Signal Advisors Wealth LLC boosted its holdings in Exelon by 5.9% in the fourth quarter. Signal Advisors Wealth LLC now owns 6,295 shares of the company’s stock valued at $274,000 after purchasing an additional 348 shares during the last quarter. Finally, World Equity Group Inc. grew its position in Exelon by 5.5% during the 4th quarter. World Equity Group Inc. now owns 18,400 shares of the company’s stock worth $802,000 after purchasing an additional 951 shares during the period. Institutional investors and hedge funds own 80.92% of the company’s stock.

Exelon Stock Down 0.2%

Exelon stock opened at $48.32 on Friday. Exelon Corporation has a 12 month low of $41.71 and a 12 month high of $50.65. The stock has a market capitalization of $49.44 billion, a PE ratio of 17.70, a price-to-earnings-growth ratio of 2.81 and a beta of 0.45. The company has a debt-to-equity ratio of 1.66, a current ratio of 0.92 and a quick ratio of 0.84. The business has a 50 day simple moving average of $47.06 and a 200-day simple moving average of $45.76.

Exelon (NASDAQ:EXC) last released its quarterly earnings results on Thursday, February 12th. The company reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.55 by $0.04. Exelon had a net margin of 11.41% and a return on equity of 9.97%. The firm’s quarterly revenue was down 1.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.64 EPS. Exelon has set its FY 2026 guidance at 2.810-2.910 EPS. On average, analysts anticipate that Exelon Corporation will post 2.64 EPS for the current fiscal year.

Exelon Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, March 2nd were paid a dividend of $0.42 per share. This is an increase from Exelon’s previous quarterly dividend of $0.40. This represents a $1.68 dividend on an annualized basis and a dividend yield of 3.5%. The ex-dividend date of this dividend was Monday, March 2nd. Exelon’s dividend payout ratio is presently 61.54%.

Wall Street Analyst Weigh In

EXC has been the topic of a number of recent research reports. Scotiabank upped their target price on Exelon from $46.00 to $47.00 and gave the stock a “sector perform” rating in a research note on Friday, February 13th. KeyCorp upped their price objective on Exelon from $39.00 to $44.00 and gave the stock an “underweight” rating in a research report on Wednesday, March 4th. UBS Group raised their price objective on shares of Exelon from $48.00 to $51.00 and gave the stock a “neutral” rating in a research note on Friday, February 20th. Barclays cut their target price on shares of Exelon from $52.00 to $50.00 and set an “overweight” rating for the company in a report on Thursday, January 22nd. Finally, Morgan Stanley reiterated an “underperform” rating and issued a $51.00 target price on shares of Exelon in a research note on Wednesday, January 21st. Nine analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $51.40.

Exelon Profile

Exelon Corporation (NASDAQ: EXC) is a Chicago-based energy company that operates primarily as a regulated electric and natural gas utility holding company. The company’s businesses focus on the delivery of electricity and related services to residential, commercial and industrial customers, as well as investments in grid modernization, customer energy solutions and demand-side programs. Exelon’s operations emphasize reliable service delivery, infrastructure maintenance and regulatory compliance across its utility footprint.

Formed in 2000 through the merger of Unicom and PECO Energy, Exelon historically combined generation and regulated utility businesses.